trial · primary record
HRS-4642 + AG
KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 588 |
| Primary completion | 2029-04 |
| Primary endpoint | PFS as assessed by BICR per RECIST 1.1 |
| Registry ID | NCT07232875 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:22.939Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07232875
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.